[{"from": "human", "value": "Create a molecule that satisfies the conditions outlined in the description. The molecule is the sodium salt form of danoprevir, an orally bioavailable, peptidomimetic inhibitor of hepatitis C virus (HCV) NS3/4A protease, with antiviral activity against HCV and potential antiviral activity against SARS-CoV-2. Upon oral administration, danoprevir binds to and blocks the activity of HCV NS3/4A protease. This prevents the cleavage and processing of HCV viral proteins leading to the inhibition of HCV replication. Danoprevir may also bind to and block of the activity of SARS-CoV-2 protease. This prevents the cleavage and processing of SARS-CoV-2 viral proteins leading to the inhibition of SARS-CoV-2 replication. NS3/4A, a chymotrypsin-like serine protease, is responsible for cleavage at four sites of the HCV polyprotein to form the viral proteins required for HCV replication. It plays a key role in the HCV viral replication process. HCV infection is associated with the development of hepatocellular carcinoma (HCC). A chymotrypsin-like protease is responsible for cleavage of the SARS-CoV-2 viral polyprotein to form the RNA replicase-transcriptase complex, which plays a key role in the SARS-CoV-2 viral transcription and replication process."}, {"from": "gpt", "value": "[C][C][Branch1][C][C][Branch1][C][C][O][C][=Branch1][C][=O][N][C@H1][C][C][C][C][C][/C][=C][\\C@@H1][C][C@][Ring1][Ring1][Branch2][Ring2][O][N][C][=Branch1][C][=O][C@@H1][C][C@H1][Branch1][#Branch2][C][N][Ring1][Branch1][C][Ring2][Ring1][Ring2][=O][O][C][=Branch1][C][=O][N][C][C][=C][Branch1][Ring2][C][Ring1][Branch1][C][=Branch1][=Branch1][=C][C][=C][Ring1][#Branch1][F][C][=Branch1][C][=O][N-1][S][=Branch1][C][=O][=Branch1][C][=O][C][C][C][Ring1][Ring1].[Na+1]"}]